Edwardsiella tarda immunogenic protective antigen, and related expression vector, vaccine and application
A technology of protective antigen and expression vector, applied in the field of immune protective antigen and antigen, can solve the problems of increasing the difficulty of antibiotic treatment and application limitations, and achieve the effect of being suitable for large-scale promotion and application.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] The preparation of embodiment 1 recombinant protein vaccine
[0026] 1. Experimental materials
[0027] 1. Strains and plasmids
[0028] Escherichia coli TOP10 and E. coli BL21 (DE3) were purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd.; Edwardsiella tarda E. tarda EIB202, the preservation number is: CCTCC M 208068; pET 28a (+) vector Purchased from Bao Biological Engineering (Dalian) Co., Ltd.
[0029] 2. Medium and culture conditions
[0030] Medium:
[0031]LB: 1% Tryptone, 0.5% Yeast extract, 1% NaCl. Add 2% ager to the solid medium. Autoclave at 121°C for 20 minutes. For the cultivation of Escherichia coli.
[0032] TSB: 3% TSB. Add 2% ager to the solid medium. Autoclave at 121°C for 20 minutes. For EIB202 culture.
[0033] DHL medium: 60g of gallic acid milk agar medium was dissolved in 1L of deionized water, boiled repeatedly to dissolve until clear, and made a plate after cooling.
[0034] Training conditions:
[0035] Escherichia c...
Embodiment 2
[0056] Embodiment 2: Taking zebrafish as the experimental animal's immune protection test by injection
[0057] Protein Concentration Determination
[0058] The OD280 of the nucleic acid quantification instrument NanoDrop ND-1000 spectrophotometer was detected to determine the concentration of the recombinant protein, and the protein was diluted to a predetermined concentration with PBS buffer.
[0059] Immunization of zebrafish
[0060] The purified FD recombinant protein was mixed with the adjuvant ISA 763A at a ratio of 7:3, and the final protein concentration was 0.3 μg / μl. Zebrafish were cultured in random groups, 30 fish / group, and each zebrafish was immunized by tail intramuscular injection. Then feed them normally, observe the activity and death of the fish. Immunization time is one month. The negative control was the mixed group of PBS and adjuvant.
[0061] Before the injection operation, the zebrafish was soaked in 100ng / ml MS-222 for anesthesia. After the end...
Embodiment 3
[0070] Embodiment 3: Taking turbot as the experimental animal's immune protection test by injection
[0071] Immunization of turbot
[0072] Turbot were cultured in random groups, 30 fish / group, and each fish was intramuscularly injected into the tail at a dose of 100 μl / fish. After the purified protein was dialyzed overnight, according to its concentration, it was mixed with the adjuvant ISA 763A at a ratio of 7:3 until the protein concentration reached 0.3 μg / μl. PBS and adjuvant ISA 763A immunization group were negative controls. Then feed them normally, observe the fish's activities and whether they die. The immunization time is 10 weeks.
[0073] Before the injection operation, soak the turbot in 100ng / ml MS-222 for anesthesia. After the experimental period, the remaining turbot were euthanized by soaking in 300 ng / ml MS-222 for more than 10 minutes.
[0075] The challenge method of turbot is the same as that of zebrafish. After the turbot is ...
PUM

Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com